Jonna B Westover, Kie Hoon Jung, Cigdem Alkan, Kirsten M Boardman, Arnaud J Van Wettere, Craig Martens, Inioska Rojas, Philip Hicks, Aaron J Thomas, Manohar T Saindane, Gregory R Bluemling, Shuli Mao, Alexander A Kolykhalov, Michael G Natchus, Paul Bates, George R Painter, Tetsuro Ikegami, Brian B Gowen
UNLABELLED: Heartland virus (HRTV) is an emerging tick-borne bandavirus that causes a febrile illness of varying severity in humans, with cases reported in eastern and midwestern regions of the United States. No vaccines or approved therapies are available to prevent or treat HRTV disease. Here, we describe the genetic changes, natural history of disease, and pathogenesis of a mouse-adapted HRTV (MA-HRTV) that is uniformly lethal in 7- to 8-week-old AG129 mice at low challenge doses. We used this model to assess the efficacy of the ribonucleoside analog, 4'-fluorouridine (EIDD-2749), and showed that once-daily oral treatment with 3 mg/kg of drug, initiated after the onset of disease, protects mice against lethal MA-HRTV challenge and reduces viral loads in blood and tissues...
March 21, 2024: Journal of Virology